Published in Medical Letter on the CDC and FDA, April 13th, 2003
According to a study from the United States, "A total of 26 postmarketing cases of allergic contact dermatitis to doxepin 5% cream were reported to the Food and Drug Administration."
"Our findings suggest that allergic contact dermatitis was more common when treatment duration exceeded the recommended 8 days," said Renan A. Bonnel and collaborators at the Food and Drug Administration. "Allergic contact dermatitis to doxepin cream should be considered in patients whose...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.